CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sturm, R. A.
Right arrow Articles by Parsons, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sturm, R. A.
Right arrow Articles by Parsons, P. G.

Cell Growth & Differentiation, Vol 2, Issue 10 519-524, Copyright © 1991 by American Association of Cancer Research


ARTICLES

A melanoma octamer binding protein is responsive to differentiating agents

RA Sturm, F Bisshop, H Takahashi and PG Parsons
Centre for Molecular Biology and Biotechnology, University of Queensland, Australia.

Analysis of human melanocytes and melanoma cell lines for proteins interacting with the octamer control sequence (ATGCAAAT) has revealed two distinct melanoma octamer binding proteins, Oct-M1 and Oct-M2. The latter was restricted to cell lines derived from tumor metastases. The level of Oct-M1 activity in a pigmented melanoma line was enhanced in comparison to the general octamer binding protein Oct-1 when cells were cultured in the presence of the depigmenting agent dithiothreitol and conversely was reduced by the differentiating and pigment inducing agents butyric acid and dimethyl sulfoxide.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
J. Goodall, C. Wellbrock, T. J. Dexter, K. Roberts, R. Marais, and C. R. Goding
The Brn-2 Transcription Factor Links Activated BRAF to Melanoma Proliferation
Mol. Cell. Biol., April 1, 2004; 24(7): 2923 - 2931.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. M. Cutts, P. G. Parsons, R. A. Sturm, and D. R. Phillips
Adriamycin-induced DNA Adducts Inhibit the DNA Interactions of Transcription Factors and RNA Polymerase
J. Biol. Chem., March 8, 1996; 271(10): 5422 - 5429.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1991 by the American Association of Cancer Research.